Alejandro González-Caldevilla

Cirujano cardiovascular e historiador del arte. Revisionista de Tolkien. Cardiovascular surgeon consultant at Córdoba 🇪🇸 🫀MD, FETCS

[Alejandro González-Caldevilla @choparuman]

https://t.co/iEujfzVise

[UGC Cardiovascular @CirugiaCVHURS]

Alejandro González-Caldevilla, @choparuman , cirujano de nuestra unidad en @HUReinaSofia , presenta la cirugía de la válvula aórtica mediante minitoracotomía anterior derecha 🫀

https://t.co/AjUHKNjRiD

[Victor Dayan @VictorDayan1]

🚨More rehospitalizations (x2) after TAVR in EARLY TAVR (26%) than in PARTNER 3 (13%) at 5y— despite asymptomatic patients and similar STS risk? Slightly higher age in EARLY TAVR is no excuse.
If the idea was to intervene earlier, it’s hard to see where the benefit lies.

[Victor Dayan @VictorDayan1]

🚑BREAKING NEWS. This is massive. 10 year PARTNER 2 data has been released by the company. No statistical analyses were performed. But I performed them and these is what happened at 10 years. @pomyers @rafasadaba @STS_CTsurgery @EACTS

[Alejandro González-Caldevilla @choparuman]

What a great time it has been! Immensely proud to say that I worked with you and will always have a place in my heart (probably close to the aortic root 😉). I am sure we will see each other soon @mraungoo @ru_nhs @BartsAorta

[Barts Aortic Surgery @BartsAorta]

New aortic designs by the talented artist and surgeon @choparuman Alejandro Gonzalez Caldevilla, who sadly has finished his period at Barts to start a Consultant career back in Spain. Good luck Alex and hope our paths cross back again. @mraungoo

[Rafa Sádaba @rafasadaba]

In Partner 2A and 3, SAVR makes you live longer than TAVI…the longer the follow up, the clearer the benefits of SAVR…@VictorDayan1

https://t.co/F5bsryB0ur

https://t.co/ritDUTqud0

[Manuel Carnero @manuel_carnero]

10y PARTNER II outcomes🫣😱

https://t.co/V8PoPRLn2d

[ovd @_oviedista]

Melendi y la Real Banda de Gaitas Ciudad de Oviedo
tocando ante casi 4 millones de personas el himno de Asturias y enseñando su camiseta del Real Oviedo con el 8 de don Santiago Cazorla. Histórico.

[Javi Moreiras @jmmoreiras]

Hoy es un día imp. Depende de nosotros que trabajemos las horas justas (como todos los trabajadores), cobremos y coticemos las guardias (como son, horas extraordinarias) y recuperemos algo de dignidad de nuestra profesión, que es importante excepto si hablamos de €. Así NO!

[David Rozo @DonIzquierdo_]

“No se cansen de ser buenos, aunque ser bueno no sirve para mucho. Sirve para no arrepentirse con uno mismo”, Pepe Mujica, 1935 - 2025.

😭

[Alejandro González-Caldevilla @choparuman]

Day 1 of one of the most exciting meetings regarding integral aortic disease management !! #CXSymposium25
Great faculty talks and discussions ahead.
Let’s go!

[Alejandro González-Caldevilla @choparuman]

@josecaferca Right mini-thoracotomy with beating heart surgery. Ring annuloplasty + cleft closure 🤗

[Stefano Urso @StefanoUrsoMD]

Surgical versus Transcatheter Aortic Valve Replacement in Patients 65 Years of Age and Older - The Annals of Thoracic Surgery https://t.co/gEvS2BJNSm

[Alejandro González-Caldevilla @choparuman]

@CarlotaTormes @erodcauCCV No creo que sea inédito. En Córdoba se lleva haciendo desde hace 15 años. Me alegro de que se vaya ampliando la cartera de servicios del país!

[Alejandro González-Caldevilla @choparuman]

@BabliakD @OrchidSurgical My email is [email protected]. I’ll be grateful if you could share it with me too!

[George Tolis @georgetolisjr]

I truly wonder what would have happened 50 years ago if the hospital requested Cooley, Debakey or Kolesov to complete some Healthstream training modules and CDI queries.

[Alejandro González-Caldevilla @choparuman]

Watching @IHamamsy talking about Ross procedure is just fascinating.
Brilliant presentation and many take home messages ! #EACTS2024

[Aung Oo @mraungoo]

@aorticsurgeon talking about risk stratification in TAAA patients. Insights into physiological and anatomical risks and their modifications. @BartsAorta #CX Vienna aortic live 2024

[Victor Dayan @VictorDayan1]

MATTERHORN trial. TEER vs Surgery. A trial which aims to evaluate is TEER is better than surgery when we still do not know if it is better than medical treatment. These are my comments…https://t.co/jD587bccxK. @drjohnm @rafasadaba @pomyers @EduQuintanaCVS @michaelTCTMD

[Alejandro González-Caldevilla @choparuman]

@rsegalote @Giam00 @AorticAssociat2 @AorticC @aorticamx @CuoreVzla @svcceoficial Hoping that is LVOT is wide enough…